Thyroid disease and the heart.

The cardiovascular signs and symptoms of thyroid disease are some of the most profound and clinically relevant findings that accompany both hyperthyroidism and hypothyroidism. On the basis of the understanding of the cellular mechanisms of thyroid hormone action on the heart and cardiovascular system, it is possible to explain the changes in cardiac output, cardiac contractility, blood pressure, vascular resistance, and rhythm disturbances that result from thyroid dysfunction. The importance of the recognition of the effects of thyroid disease on the heart also derives from the observation that restoration of normal thyroid function most often reverses the abnormal cardiovascular hemodynamics. In the present review, we discuss the appropriate thyroid function tests to establish a suspected diagnosis as well as the treatment modalities necessary to restore patients to a euthyroid state. We also review the alterations in thyroid hormone metabolism that accompany chronic congestive heart failure and the approach to the management of patients with amiodarone-induced alterations in thyroid function tests.

[1]  S. Olsson,et al.  Long QT interval and ventricular tachycardia of "torsade de pointe" type in hypothyroidism. , 2009, Acta medica Scandinavica.

[2]  W. Bremner,et al.  Advances in male contraception. , 2008, Endocrine reviews.

[3]  B. Gloss,et al.  Adeno-associated virus-mediated expression of thyroid hormone receptor isoforms-alpha1 and -beta1 improves contractile function in pressure overload-induced cardiac hypertrophy. , 2007, Endocrinology.

[4]  J. Weaver,et al.  The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. , 2007, The Journal of clinical endocrinology and metabolism.

[5]  L. Vatten,et al.  Association between blood pressure and serum thyroid-stimulating hormone concentration within the reference range: a population-based study. , 2007, The Journal of clinical endocrinology and metabolism.

[6]  F. Bogazzi,et al.  Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations. , 2007, The Journal of clinical endocrinology and metabolism.

[7]  J. Franklyn,et al.  Cardiovascular manifestations of hyperthyroidism before and after antithyroid therapy: a matched case-control study. , 2007, Journal of the American College of Cardiology.

[8]  A. Divani,et al.  Free thyroxine index and risk of stroke: results from the National Health and Nutrition Examination Survey Follow-up Study. , 2006, Medical Science Monitor.

[9]  N. Takasu [Thyroid hormone and the cardiovascular system]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.

[10]  Samuel Wann,et al.  [Guidelines for the management of patients with atrial fibrillation. Executive summary]. , 2006, Revista espanola de cardiologia.

[11]  U. John,et al.  The association between subclinical hyperthyroidism and blood pressure in a population-based study , 2006, Journal of hypertension.

[12]  P. Leedman,et al.  Subclinical thyroid dysfunction and blood pressure: a community‐based study , 2006, Clinical endocrinology.

[13]  J. Romaldini,et al.  Management of amiodarone‐induced thyrotoxicosis in Latin America: an electronic survey , 2006, Clinical endocrinology.

[14]  Thomas S. Scanlan,et al.  Rapid nongenomic actions of thyroid hormone , 2006, Proceedings of the National Academy of Sciences.

[15]  D. Ascheim,et al.  Thyroid hormone and heart failure , 2006, Current heart failure reports.

[16]  I. Klein,et al.  Role of Thyroid Disease in the Development of Statin-Induced Myopathy , 2006 .

[17]  J. Gujral,et al.  Hyperthyroidism: A Secondary Cause of Isolated Systolic Hypertension , 2006, Journal of clinical hypertension.

[18]  R. Delsignore,et al.  Pulmonary hypertension is frequent in hyperthyroidism and normalizes after therapy. , 2006, European journal of internal medicine.

[19]  E. Vittinghoff,et al.  Subclinical hypothyroidism and the risk of coronary heart disease: a meta-analysis. , 2006, The American journal of medicine.

[20]  Y. Paran,et al.  Pulmonary hypertension and predominant right heart failure in thyrotoxicosis. , 2006, Resuscitation.

[21]  L. Fried,et al.  Thyroid status, cardiovascular risk, and mortality in older adults. , 2006, JAMA.

[22]  J. García-Estañ,et al.  Vascular and renal function in experimental thyroid disorders. , 2006, European journal of endocrinology.

[23]  A. Gerdes,et al.  Thyroid hormone activates Akt and prevents serum starvation-induced cell death in neonatal rat cardiomyocytes. , 2005, Journal of molecular and cellular cardiology.

[24]  Irwin Klein,et al.  Effect of serum triiodothyronine on regulation of cardiac gene expression: role of histone acetylation. , 2005, American journal of physiology. Heart and circulatory physiology.

[25]  J. Harney,et al.  Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans. , 2005, The Journal of clinical investigation.

[26]  G. Kahaly,et al.  Thyroid hormone action in the heart. , 2005, Endocrine reviews.

[27]  W. So,et al.  Thyrotoxicosis and pulmonary hypertension. , 2005, The American journal of medicine.

[28]  J. Franklyn,et al.  Thyroid function and mortality in patients treated for hyperthyroidism. , 2005, JAMA.

[29]  O. Kwon,et al.  Moyamoya disease associated with Graves disease: special considerations regarding clinical significance and management. , 2005, Journal of neurosurgery.

[30]  J. Chung,et al.  Severe coronary artery spasm can be associated with hyperthyroidism , 2005, Coronary artery disease.

[31]  I. Klein,et al.  Effect of triiodothyronine on gene transcription during cardiopulmonary bypass in infants with ventricular septal defect. , 2005, The American journal of cardiology.

[32]  Henry Völzke,et al.  The association of thyroid function with cardiac mass and left ventricular hypertrophy. , 2005, The Journal of clinical endocrinology and metabolism.

[33]  A. L'Abbate,et al.  Triiodothyronine levels for risk stratification of patients with chronic heart failure. , 2005, The American journal of medicine.

[34]  A. Bardají,et al.  Cardiovascular abnormalities in hyperthyroidism: a prospective Doppler echocardiographic study. , 2005, The American journal of medicine.

[35]  P. Vestergaard,et al.  Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study. , 2004, Archives of internal medicine.

[36]  V. Palmieri,et al.  Myocardial contractility and total arterial stiffness in patients with overt hyperthyroidism: acute effects of beta1-adrenergic blockade. , 2004, European journal of endocrinology.

[37]  L. Agellon,et al.  Regulation of the human cholesterol 7alpha-hydroxylase gene (CYP7A1) by thyroid hormone in transgenic mice. , 2004, Endocrinology.

[38]  J. Franklyn,et al.  Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. , 2004, JAMA.

[39]  I. Klein,et al.  Thyroid hormone and blood pressure regulation , 2003, Current hypertension reports.

[40]  F. Haddad,et al.  Role of Antisense RNA in Coordinating Cardiac Myosin Heavy Chain Gene Switching* , 2003, Journal of Biological Chemistry.

[41]  L. Ghiadoni,et al.  Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. , 2003, The Journal of clinical endocrinology and metabolism.

[42]  P. Ladenson,et al.  Hypothyroidism and atherosclerosis. , 2003, The Journal of clinical endocrinology and metabolism.

[43]  J. Laragh,et al.  Relevance of the plasma renin hormonal control system that regulates blood pressure and sodium balance for correctly treating hypertension and for evaluating ALLHAT. , 2003, American journal of hypertension.

[44]  L. Demers,et al.  Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease , 2003, Clinical endocrinology.

[45]  M. Christ-Crain,et al.  Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. , 2003, Atherosclerosis.

[46]  F. R. Miller,et al.  Disorders of the Thyroid , 2003 .

[47]  F. B. Davis,et al.  Nongenomic actions of thyroid hormone on the heart. , 2002, Thyroid : official journal of the American Thyroid Association.

[48]  Mathew R. Williams,et al.  Thyroidectomy using local anesthesia in critically ill patients with amiodarone-induced thyrotoxicosis: a review and description of the technique. , 2002, Thyroid : official journal of the American Thyroid Association.

[49]  H. Nakazawa,et al.  Hyperthyroidism and the management of atrial fibrillation. , 2002, Thyroid : official journal of the American Thyroid Association.

[50]  W. Dillmann Cellular action of thyroid hormone on the heart. , 2002, Thyroid : official journal of the American Thyroid Association.

[51]  L. Duntas Thyroid disease and lipids. , 2002, Thyroid : official journal of the American Thyroid Association.

[52]  E. Ferrannini,et al.  Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study. , 2002, The Journal of clinical endocrinology and metabolism.

[53]  B. Biondi,et al.  Effects of thyroid hormone on cardiac function: the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism. , 2002, The Journal of clinical endocrinology and metabolism.

[54]  P. Larsen,et al.  Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. , 2002, Endocrine reviews.

[55]  B. Biondi,et al.  Impact of Hyperthyroidism and Its Correction on Vascular Reactivity in Humans , 2001, Circulation.

[56]  J. Auer,et al.  Subclinical hyperthyroidism as a risk factor for atrial fibrillation. , 2001, American heart journal.

[57]  V. Fuster,et al.  ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conference , 2001, Circulation.

[58]  E. Kucharz,et al.  Influence of short-time application of a low sodium diet on blood pressure in patients with hyperthyroidism or hypothyroidism during therapy. , 2001, American journal of hypertension.

[59]  J. Franklyn,et al.  Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study , 2001, The Lancet.

[60]  L. Braverman,et al.  The effects of amiodarone on the thyroid. , 2001, Endocrine reviews.

[61]  W. Wiersinga,et al.  Endocrine factors related to changes in total peripheral vascular resistance after treatment of thyrotoxic and hypothyroid patients. , 2001, European journal of endocrinology.

[62]  B. Biondi,et al.  Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. , 2000, The Journal of clinical endocrinology and metabolism.

[63]  R. Koenig,et al.  Gene Regulation by Thyroid Hormone , 2000, Trends in Endocrinology & Metabolism.

[64]  W. Linssen,et al.  Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study , 2000, Journal of neurology, neurosurgery, and psychiatry.

[65]  G. Canaris,et al.  The Colorado thyroid disease prevalence study. , 2000, Archives of internal medicine.

[66]  A. Hofman,et al.  Subclinical Hypothyroidism Is an Independent Risk Factor for Atherosclerosis and Myocardial Infarction in Elderly Women: The Rotterdam Study , 2000, Annals of Internal Medicine.

[67]  N. Ishikawa,et al.  Is there a place for the late cardioversion of atrial fibrillation? A long-term follow-up study of patients with post-thyrotoxic atrial fibrillation. , 2000, European heart journal.

[68]  M. Lazar,et al.  Transcriptional Repression by Nuclear Hormone Receptors , 2000, Trends in Endocrinology & Metabolism.

[69]  A. Arroliga,et al.  High prevalence of hypothyroidism in patients with primary pulmonary hypertension. , 1999, The American journal of the medical sciences.

[70]  M. Alevizaki,et al.  Mitral valve prolapse in autoimmune thyroid disease: an index of systemic autoimmunity? , 1999, Thyroid : official journal of the American Thyroid Association.

[71]  P. Larsen,et al.  Thyroid hormone regulates hyperpolarization-activated cyclic nucleotide-gated channel (HCN2) mRNA in the rat heart. , 1999, Circulation research.

[72]  D. Mckinnon,et al.  Distribution and prevalence of hyperpolarization-activated cation channel (HCN) mRNA expression in cardiac tissues. , 1999, Circulation research.

[73]  J. Franklyn,et al.  Mortality after the treatment of hyperthyroidism with radioactive iodine. , 1998, The New England journal of medicine.

[74]  E. Park,et al.  Thyroid hormone induces beta1-adrenergic receptor gene transcription through a direct repeat separated by five nucleotides. , 1997, Journal of molecular and cellular cardiology.

[75]  L. Leinwand,et al.  Myosin heavy chain gene expression in human heart failure. , 1997, The Journal of clinical investigation.

[76]  B. Groves,et al.  Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. , 1997, The Journal of clinical investigation.

[77]  K. Ojamaa,et al.  Alterations in cardiac contractility and gene expression during low-T3 syndrome: prevention with T3. , 1997, American journal of physiology. Endocrinology and metabolism.

[78]  I. Klein,et al.  Thyroid hormone and the cardiovascular system. , 1997, The New England journal of medicine.

[79]  F. Sellke,et al.  The Direct Vasomotor Effect of Thyroid Hormones on Rat Skeletal Muscle Resistance Arteries , 1997, Anesthesia and analgesia.

[80]  D. A. Meier Werner and Ingbar's The Thyroid , 1997 .

[81]  S. Liggett,et al.  Effects of thyroid hormone on cardiac beta-adrenergic responsiveness in conscious baboons. , 1997, Circulation.

[82]  T. Visser,et al.  Uptake of thyroid hormones in neonatal rat cardiac myocytes. , 1996, Endocrinology.

[83]  F. Bogazzi,et al.  Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. , 1996, The Journal of clinical endocrinology and metabolism.

[84]  A. Pezzarossa,et al.  Power spectral analysis of heart rate in hyperthyroidism. , 1996, The Journal of clinical endocrinology and metabolism.

[85]  S. Connolly,et al.  How useful is thyroid function testing in patients with recent-onset atrial fibrillation? The Canadian Registry of Atrial Fibrillation Investigators. , 1996, Archives of internal medicine.

[86]  S. Thomas,et al.  Thyroid hormone treatment after coronary-artery bypass surgery. , 1995, The New England journal of medicine.

[87]  P. Caron [Effects of amiodarone on thyroid function]. , 1995, Presse medicale.

[88]  Y. Hirata,et al.  Hormonal regulation of rat adrenomedullin gene in vasculature. , 1995, Endocrinology.

[89]  R. D'Agostino,et al.  Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. , 1994, The New England journal of medicine.

[90]  F. Epstein,et al.  The molecular basis of thyroid hormone action. , 1994, The New England journal of medicine.

[91]  I. Klein,et al.  Beta-Adrenergic Receptor Blocking Drugs in the Management of Hyperthyroidism , 1994 .

[92]  G S Levey,et al.  Treatment of Hyperthyroid Disease , 1994, Annals of Internal Medicine.

[93]  É. Kiss,et al.  Thyroid hormone-induced alterations in phospholamban protein expression. Regulatory effects on sarcoplasmic reticulum Ca2+ transport and myocardial relaxation. , 1994, Circulation research.

[94]  C. Glass,et al.  Delineation of three different thyroid hormone-response elements in promoter of rat sarcoplasmic reticulum Ca2+ATPase gene. Demonstration that retinoid X receptor binds 5' to thyroid hormone receptor in response element 1. , 1994, The Journal of biological chemistry.

[95]  D. Krikler,et al.  Heart disease: A textbook of cardiovascular medicine , 1992 .

[96]  J. A. Franklyn,et al.  Treatment of amiodarone induced thyrotoxicosis with carbimazole alone and continuation of amiodarone. , 1992, BMJ.

[97]  P. Ladenson,et al.  Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[98]  B. Weintraub,et al.  Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. , 1992, The American journal of medicine.

[99]  I. Klein,et al.  Enhanced left ventricular diastolic function in hyperthyroidism: noninvasive assessment and response to treatment. , 1991, The Journal of clinical endocrinology and metabolism.

[100]  M. Lazar,et al.  Nuclear thyroid hormone receptors. , 1990, The Journal of clinical investigation.

[101]  M. Luu,et al.  Altered thyroid hormone metabolism in advanced heart failure. , 1990, Journal of the American College of Cardiology.

[102]  M. Bentivoglio,et al.  The effect of diltiazem, a calcium channel-blocking drug, on cardiac rate and rhythm in hyperthyroid patients. , 1988, Archives of internal medicine.

[103]  F I Gilbert,et al.  Graves' Disease: Influence of Age on Clinical Findings , 1988 .

[104]  I. Klein,et al.  Effects of thyroid hormone on cardiac size and myosin content of the heterotopically transplanted rat heart. , 1986, The Journal of clinical investigation.

[105]  D. Kim,et al.  Effects of thyroid hormone on sodium pump sites, sodium content, and contractile responses to cardiac glycosides in cultured chick ventricular cells. , 1984, The Journal of clinical investigation.

[106]  J. Amico,et al.  Clinical and chemical assessment of thyroid function during therapy with amiodarone. , 1984, Archives of internal medicine.

[107]  A. Toft,et al.  Abnormal left ventricular function in hyperthyroidism: evidence for a possible reversible cardiomyopathy. , 1982, The New England journal of medicine.

[108]  A. Khaleeli,et al.  Factors affecting resolution of pericardial effusions in primary hypothyroidism: a clinical, biochemical and echocardiographic study , 1982, Postgraduate medical journal.

[109]  A. Soutar,et al.  Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[110]  E W Bough,et al.  Noninvasive evaluation of cardiac function in hypothyroidism. Response to gradual thyroxine replacement. , 1977, The New England journal of medicine.

[111]  P. Fraser,et al.  Grades of hypothyroidism. , 1973, British medical journal.

[112]  A. Steinberg Myxedema and coronary artery disease--a comparative autopsy study. , 1968, Annals of internal medicine.

[113]  R. Segal,et al.  Thyrocardiac disease and its management with radioactive iodine I-131. , 1961, JAMA.

[114]  Samuel Wann,et al.  AMERICAN COLLEGE OF CARDIOLOGY, AMERICAN HEART ASSOCIATION AND EUROPEAN SOCIETY OF CARDIOLOGY GUIDELINES (2006) FOR THE MANAGEMENT OF PATIENTS WITH ATRIAL FIBRILLATION (ENDING) , 2007 .

[115]  E. Gaitan,et al.  Disorders of the Thyroid , 1992 .

[116]  P. Trzepacz,et al.  Hyperthyroid myopathy and the response to treatment. , 1991, Thyroid : official journal of the American Thyroid Association.

[117]  P. Petersen,et al.  Stroke in thyrotoxicosis with atrial fibrillation. , 1988, Stroke.

[118]  Christian Komusiewicz,et al.  Hyper. , 1988, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[119]  R. Volpe Immunoregulation in autoimmune thyroid disease. , 1987, The New England journal of medicine.

[120]  T. Parkin,et al.  Treatment of heart disease associated with myxedema. , 1961, Progress in cardiovascular diseases.